Transcode Therapeutics, Inc. [RNAZ] - Convertible Note Issuance
Transcode Therapeutics, Inc. has issued convertible notes, with details on terms and amounts not disclosed in the filing excerpt.
Why this matters
Transcode Therapeutics, Inc., a pharmaceutical company based in Delaware, focuses on developing innovative treatments within the pharmaceutical preparations industry. Recently, the company issued convertible promissory notes to Yorkville, agreeing to advance up to $6.0 million in two tranches. This financial maneuver was linked to a waiver executed on October 1, 2026, following a Floor Price Event where the daily VWAP of the company's stock fell below $1.72 for a significant period. As part of the waiver agreement, Transcode made a prepayment of $840,975, which included the outstanding principal, a prepayment premium, and accrued interest. This prepayment reduced the aggregate principal amount outstanding under the Convertible Notes to approximately $4.1 million.